Correlation Between Salesforce and Ventana Biotech
Can any of the company-specific risk be diversified away by investing in both Salesforce and Ventana Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Ventana Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Ventana Biotech, you can compare the effects of market volatilities on Salesforce and Ventana Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Ventana Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Ventana Biotech.
Diversification Opportunities for Salesforce and Ventana Biotech
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Ventana is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Ventana Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventana Biotech and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Ventana Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventana Biotech has no effect on the direction of Salesforce i.e., Salesforce and Ventana Biotech go up and down completely randomly.
Pair Corralation between Salesforce and Ventana Biotech
Considering the 90-day investment horizon Salesforce is expected to generate 0.18 times more return on investment than Ventana Biotech. However, Salesforce is 5.66 times less risky than Ventana Biotech. It trades about 0.21 of its potential returns per unit of risk. Ventana Biotech is currently generating about -0.21 per unit of risk. If you would invest 29,889 in Salesforce on August 30, 2024 and sell it today you would earn a total of 3,112 from holding Salesforce or generate 10.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Ventana Biotech
Performance |
| Timeline |
| Salesforce |
| Ventana Biotech |
Salesforce and Ventana Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Ventana Biotech
The main advantage of trading using opposite Salesforce and Ventana Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Ventana Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventana Biotech will offset losses from the drop in Ventana Biotech's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Ventana Biotech vs. Green Planet Bio | Ventana Biotech vs. Azure Holding Group | Ventana Biotech vs. Four Leaf Acquisition | Ventana Biotech vs. Opus Magnum Ameris |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |